Stocklytics Platform

Score (Market)

publish
The Stocklytics Scoring system delivers a well-rounded evaluation, helping investors identify stocks that excel in critical areas. Whether you're focused on value investing, dividend income, or growth potential, our ranking system gives you the clarity needed to make informed investment decisions.
name
arrow_downwardScore languageValue languageQuality languageOwnership languageGrowth languageDividends languagePrice % Change
Asset logo for symbol UNCY
UNCYUnicycive Therapeutics
$0.44arrow_drop_down4.34%AI Analysis
CSLM
CSLMConsilium Acquisition Corp I, Ltd.
$11.39arrow_drop_up0.44%AI Analysis
Asset logo for symbol CERE
CERECerevel Therapeutics Holdings
$44.960.00%AI Analysis
Asset logo for symbol INDP
INDPIndaptus Therapeutics
$1.38arrow_drop_down2.12%AI Analysis
ALCY
ALCYAlchemy Investments Acquisition Corp 1 - Class A Ordinary Shares
$10.86arrow_drop_down0.06%AI Analysis
Asset logo for symbol RDIB
RDIBReading International
$8.59arrow_drop_up8.59%AI Analysis
Asset logo for symbol LVWR
LVWRLivewire Group
$6.30arrow_drop_up1.61%AI Analysis
Asset logo for symbol RFIL
RFILRF Industries Ltd
$3.78arrow_drop_up1.88%AI Analysis
Asset logo for symbol LWLG
LWLGLightwave Logic
$2.81arrow_drop_up1.44%AI Analysis
Asset logo for symbol W
WWayfair
$52.55arrow_drop_down0.56%AI Analysis
Asset logo for symbol FCUV
FCUVFocus Universal
$0.35arrow_drop_down6.13%AI Analysis
Asset logo for symbol HCWB
HCWBHCW Biologics
$0.64arrow_drop_up4.99%AI Analysis
Asset logo for symbol MGIH
MGIHMillennium Group International Holdings Limited - Ordinary Shares
$1.62arrow_drop_down3.57%AI Analysis
Asset logo for symbol GLUE
GLUEMonte Rosa Therapeutics
$6.08arrow_drop_down6.09%AI Analysis
IRAA
IRAAIris Acquisition
$10.81arrow_drop_down1.63%AI Analysis
Asset logo for symbol RH
RHRH
$345.64arrow_drop_up0.39%AI Analysis
Asset logo for symbol PRPL
PRPLPurple Innovation
$1.02arrow_drop_down1.44%AI Analysis
Asset logo for symbol ACXP
ACXPAcurx Pharmaceuticals
$1.83arrow_drop_down8.48%AI Analysis
Asset logo for symbol TVTX
TVTXTravere Therapeutics
$14.97arrow_drop_down1.57%AI Analysis
NXG
NXGNXG NextGen Infrastructure Income Fund
$40.98arrow_drop_up0.75%AI Analysis
Showing 4381-4400 of 4977
Results per page:

When making investment decisions, a holistic view is essential. The Stocklytics Score provides just that—ranking stocks based on five key factors to give you a comprehensive evaluation. With our Market Score, stocks are ordered by our proprietary scoring system, so you can quickly identify top opportunities. The Stocklytics Score is a powerful combination of: - Value Scoring – Find stocks that offer the best value based on fundamental metrics like price-to-earnings and price-to-sales ratios. - Quality Scoring – Invest with confidence by identifying high-quality companies with strong financials and consistent performance. - Ownership Scoring – Analyze institutional and insider ownership to get a sense of the confidence level from key stakeholders. - Growth Scoring – Discover companies with the potential for above-average earnings and revenue growth. - Dividends Scoring – Focus on stocks with strong dividend yields and sustainable payout ratios for long-term income generation. The Stocklytics Scoring system delivers a well-rounded evaluation, helping investors identify stocks that excel in critical areas. Whether you're focused on value investing, dividend income, or growth potential, our ranking system gives you the clarity needed to make informed investment decisions. Why Use the Stocklytics Score? - Comprehensive View: Assess multiple factors at once to get a balanced perspective. - Data-Driven: Rely on a scoring system built from reliable financial data and market insights. - Actionable Rankings: Prioritize stocks based on their overall score or by individual factors like value or growth.
toolkit image

Discover the Power of Stocklytics Tools

Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.

See Stocklytics Tools

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level